# NatWest Group (NWG.L) Stock Analysis: Exploring a 28% Potential Upside for Investors

- Link: https://www.directorstalkinterviews.com/natwest-group-nwg-l-stock-analysis-exploring-a-28-potential-upside-for-investors/4121244620
- Published: 2026-03-16T05:09:15+00:00
- Author: Katherine Hargreaves

[NatWest Group plc](https://www.directorstalkinterviews.com/ftse-company/natwest-group-plc/nwg.l)(
LON: NWG), a prominent player in the regional banking sector, is capturing investor
attention with its substantial 28% potential upside, according to recent analyst
ratings. As a key component of the United Kingdom’s financial services landscape,
NatWest Group’s market capitalization stands at a robust $45 billion, underscoring
its significant presence in the industry.

#### Current Market Performance and Valuation

NatWest’s current stock price is 565.2 GBp, slightly down by 0.01%, which places
it within the lower end of its 52-week range of 411.20 to 694.20 GBp. This positioning
offers an intriguing entry point for investors considering its average target price
of 723.77 GBp, suggesting a notable upside potential.

Despite the lack of certain valuation metrics, such as trailing P/E and PEG ratio,
the forward P/E is notably high at 689.18, which could be an indicator of market
expectations for future earnings growth. The absence of a price-to-book ratio further
emphasizes the need for investors to consider alternative metrics and market sentiment
when evaluating NatWest.

#### Financial Performance Highlights

NatWest’s performance metrics reveal a positive trajectory, with revenue growth 
reported at 11.40%. The company’s earnings per share (EPS) stands at 0.67, which,
alongside a return on equity of 14.23%, reflects a strong profitability level. However,
net income and free cash flow data are currently unavailable, which might pose a
challenge for those seeking a comprehensive financial assessment.

Investors may find comfort in NatWest’s dividend profile, which boasts a healthy
yield of 5.75% and a payout ratio of 37.09%. This combination suggests a sustainable
dividend policy that could appeal to income-focused investors seeking reliable returns
amidst market volatility.

#### Analyst Ratings and Future Prospects

Analyst sentiment towards NatWest is predominantly positive, with 11 buy ratings
and 6 hold ratings, and no sell ratings. This suggests a favorable outlook from 
the investment community. The target price range between 600.00 and 840.00 GBp, 
coupled with an average target of 723.77 GBp, indicates significant room for growth.

Technical indicators present a mixed picture; the stock’s 50-day moving average 
is 625.30 GBp, above the current price, while the 200-day moving average is slightly
higher at 570.34 GBp. An RSI of 34.37 suggests the stock is nearing oversold territory,
potentially indicating a buying opportunity for investors looking to capitalize 
on market corrections. However, a negative MACD of -15.85 against a signal line 
of -13.59 might suggest caution as it implies a bearish trend.

#### Strategic Positioning and Operations

NatWest Group’s diversified operations across retail, private, and commercial banking
segments equip it with a robust business model. Its services range from personal
banking to wealth management and institutional banking, offering a comprehensive
suite of financial products. This diversification not only mitigates risk but also
positions NatWest to capture growth across various economic sectors.

Founded in 1727 and rebranded from The Royal Bank of Scotland Group plc to NatWest
Group plc in 2020, the company has a longstanding history and reputation that could
appeal to investors seeking stability and legacy in their investment portfolios.

For investors considering exposure to the financial services sector, NatWest Group
presents an appealing case with its potential upside, strong revenue growth, and
attractive dividend yield. However, careful consideration of valuation metrics and
technical indicators, as well as the broader market environment, will be crucial
in making an informed investment decision.

Share on:
